Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
作者:
主题词
佐剂, 免疫(Adjuvants, Immunologic);动物(Animals);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);树突细胞(Dendritic Cells);表位, B淋巴细胞(Epitopes, B-Lymphocyte);表位, T淋巴细胞(Epitopes, T-Lymphocyte);女(雌)性(Female);口蹄疫(Foot-and-Mouth Disease);口蹄疫病毒(Foot-and-Mouth Disease Virus);免疫, 细胞(Immunity, Cellular);外源凝集素类(Lectins);小鼠(Mice);结核分枝杆菌(Mycobacterium tuberculosis);重组融合蛋白质类(Recombinant Fusion Proteins);Toll样受体4(Toll-Like Receptor 4);疫苗, 亚单位(Vaccines, Subunit);病毒疫苗(Viral Vaccines)
DOI
10.1016/j.molimm.2020.02.018
PMID
32199211
发布时间
2020-07-13
- 浏览0
Molecular immunology
118-126页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文